I heard about immunotherapy from my doctor, and when I found that out, I just had hope.
Just before Christmas in 2014, Debbie Guadagno was looking forward to spoiling her grandkids with presents and spending time at family events. She had no idea that a tumor the size of a football was growing on her kidney until a routine blood test showed elevated calcium levels and she was sent for further testing. Scans showed that the kidney cancer had spread to her liver, lung, and spine.
Told she had 18 months to live at best, she found her way “through a stroke of luck” into a clinical trial testing a combination of two immunotherapies — ipilimumab (Yervoy®) and nivolumab (Opdivo®) — as a first-line treatment following surgical removal of the tumor. With the help of her husband, Gary, and sister, Cindy, Debbie made it to all her appointments, receiving treatment for two years before going off the trial. Four years after her diagnosis, she was declared cancer-free by her medical team.
